Clinical Trial Update: Adjuvant Immunotherapy After Salvage Surgery in Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry reports a Phase 2 trial evaluating adjuvant immunotherapy after salvage surgery for head and neck squamous cell carcinoma; recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING